1. ALLA AKTIER
  2. NYHETER
  3. VÄSTRA HAMNEN CORP. FINANCE

Västra Hamnen Corp. Finance

Nyheter Västra Hamnen Corp. Finance Nyheter alla bolag

Bioextrax: Still awaiting the potential to materialise

  • Expecting agreements to materialise
  • Costs still in check
  • We keep our fair value to SEK 4.23 per share

Bioextrax reported figures close to our estimates in its recent Q2 report. Revenues of MSEK 0.5 were slightly higher than expected, while costs also came in above forecast. The cash position was MSEK 3.4 higher than our estimate, mainly due to subscribed but not paid-up share capital, where a receivable of MSEK 2 was paid off during the quarter. The company made multiple advances in its projects, setting the stage for an exciting second half of the year.

Read the full report here

About Market Focus

The research report is prepared as part of Market Focus, Västra Hamnen Corporate Finance's commissioned research offering.

This is a press release from Västra Hamnen Corporate Finance AB. 
Web: vhcorp.se
Twitter: @vhcorp_se (https://x.com/vhcorp_se)

Datum 2025-08-28, kl 12:05
Källa MFN
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!